About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00792402

Computerized Guideline in Heart Failure: Implementation Process and Impact Evaluation

Objective: To assess the effectiveness of implementation process of an electronic Heart Failure guideline in primary care in the city of Barcelona.

Lead sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Collaborators

Catalan Institute of Health

Design: Two types of design will be applied, according to the specific aims. On the one hand it is a cross-sectional and a qualitative study, on the other hand it is quasi-experimental study. Pre-post intervention with a control group, as well as, of repeated measures in the intervention group

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•general and nurse primary care practitioners working in Barcelona and Girona for the Health Catalan Institute.
•Managers involved in implementation process for the computerised clinical guideline in Barcelona from the Health Catalan Institute.
•patients with diagnoses of Heart Failure according to ICD-10 according to general practice clinical records.

Exclusion Criteria

•Managers and general and nurse primary care practitioners working in Barcelona health Centres where there were any other quality improvement project related to Heart failure at the time of the intervention which we are evaluating. Managers from the control group (Girona).
•patients with a mental health disorder or terminal illness

Related studies

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

NCT05666518 · Chronic Heart Failure

Effects of Resistance Training on Sarcopenia in Older Patients With Chronic Heart Failure

NCT06785168 · Sarcopenia in Elderly, Chronic Heart Failure

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

NCT06659393 · Pediatric Chronic Heart Failure

Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study

NCT04471129 · Chronic Heart Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 23, 2011Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment13,008

Start dateNov 2007

Last updatedNov 23, 2011

Condition

Chronic Heart Failure

Locations shown

Unitat de Suport a la Recerca

Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions